In the present study, we demonstrated that PAs have cytoprotective effects on normal human CD4+ T lymphocytes but not on Jurkat or K562 cancer cells, and such protection is associated with the induction of the alternative splicing of RAD51 pre-mRNA. Here, CD4 is linked to cancer.